Cancer News: Sarcoma
New combination-treatment for advanced soft tissue sarcoma
The FDA granted approval to olaratumab with doxorubicin combination treatment for patients with advanced soft tissue sarcoma (STS).
Immunotherapy pembrolizumab gives hope to some sarcoma patients
The existing cancer immunotherapy pembrolizumab induced positive outcomes to patients with undifferentiated pleomorphic sarcoma.
What is the best available treatment for soft tissue sarcoma?
Pulmonary metastasectomy was associated to prolonged survival in patients with metastatic soft tissue sarcoma, a new data analysis shows.
Soft tissues sarcomas: Europe gets one step closer to treatment
EU regulators have approved eribulin for the treatment of adult patients with unresectable liposarcomas.
Radiation benefited older patients with soft tissue sarcomas
Older patients with soft tissue sarcomas responded better to radiation therapy following surgery compared to their younger counterparts, a new study reveals.
FDA approves breast cancer drug Halaven for liposarcoma
Eisai’s breast cancer drug eribulin mesylate (Halaven) received FDA’s approval to treat patients with liposarcoma.
New treatment option approved for soft-tissue sarcoma
U.S regulators approved trabectedin (Yondelis) for the treatment of certain types of unresectable or metastatic soft-tissue sarcomas.
Trabectedin brings hope to advanced soft tissue sarcoma patients
Trabectedin (Yondelis) reduced the risk of disease progression in the largest randomized Phase 3 study ever conducted in patients advanced soft tissue sarcoma.
Efficacy of soft-tissue sarcoma treatment confirmed
A large study of Yondelis in soft-tissue sarcoma patients confirms the drug is effective in delaying progression, even more than in clinical trials.
Advanced soft tissue sarcoma: new and confirmed prognostic factors
An analysis has confirmed the importance of known prognostic factors for the long-term outcome in treatment with pazopanib for metastatic soft tissue sarcoma.
Sarcoma growth slowed in trial testing new therapeutic combination
A small clinical trial has tested new treatment combination against resistant sarcomas. The results show that the growth of these tumors can be stabilized.